These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 378854)

  • 1. Kinetics of lymphocyte transformation in mice immunized with viable avirulent forms of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Infect Immun; 1979 May; 24(2):449-53. PubMed ID: 378854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
    Fromtling RA; Blackstock R; Hall NK; Bulmer GS
    Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
    Fromtling RA; Kaplan AM; Shadomy HJ
    Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppression by avirulent, pseudohyphal forms of Cryptococcus neoformans.
    Blackstock R; Hall NK
    Mycopathologia; 1982 Nov; 80(2):95-9. PubMed ID: 6759943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on direct anticryptococcal activities of murine T lymphocytes.
    Muth SM; Murphy JW
    Infect Immun; 1995 May; 63(5):1645-51. PubMed ID: 7729868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s).
    Khakpour FR; Murphy JW
    Infect Immun; 1987 Jul; 55(7):1657-62. PubMed ID: 2954914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interactions of immune lymphocytes and Cryptococcus neoformans.
    Fung PY; Murphy JW
    Infect Immun; 1982 Jun; 36(3):1128-38. PubMed ID: 7047393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate hypersensitivity to Cryptococcus neoformans.
    Tang YJ; Morelli R
    Infect Immun; 1981 Feb; 31(2):842-4. PubMed ID: 7012025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of mice with a mutant of Cryptococcus neoformans. Characterization of the mutant, actively acquired resistance to experimental cryptococcosis in mice.
    Reiss F; Alture-Werber E
    Dermatologica; 1976; 152(1):16-22. PubMed ID: 780165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection.
    Lindell DM; Ballinger MN; McDonald RA; Toews GB; Huffnagle GB
    Infect Immun; 2006 Aug; 74(8):4538-48. PubMed ID: 16861640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.
    Miller GP; Puck J
    J Immunol; 1984 Jul; 133(1):166-72. PubMed ID: 6373927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional testing and chemical composition of cryptococcal extracts.
    Hall NK; Maluf KC; Blackstock R
    Sabouraudia; 1984; 22(5):439-42. PubMed ID: 6390739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.
    Lim TS; Murphy JW
    Infect Immun; 1980 Oct; 30(1):5-11. PubMed ID: 7002791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticryptococcal cytotoxicity of murine nonadherent cells is perforin and nonperforin mediated.
    Petković L; Arsenijević VA; Skvarc M; Kopitar A; Kotnik V; Simicic S; Wraber B; Matos T; Ihan A
    Mycologia; 2010; 102(3):552-9. PubMed ID: 20524588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection.
    Schimpff SC; Bennett JE
    J Allergy Clin Immunol; 1975 Jun; 55(6):430-41. PubMed ID: 1094054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.
    Mody CH; Syme RM
    Infect Immun; 1993 Feb; 61(2):464-9. PubMed ID: 8423074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity.
    Murphy JW
    Infect Immun; 1985 May; 48(2):439-45. PubMed ID: 3157646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of CD4+ (L3T4+) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans.
    Mody CH; Lipscomb MF; Street NE; Toews GB
    J Immunol; 1990 Feb; 144(4):1472-7. PubMed ID: 1968080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of responses to cryptococcal antigen in murine cryptococcosis.
    Robinson BE; Hall NK; Bulmer GS; Blackstock R
    Mycopathologia; 1982 Dec; 80(3):157-63. PubMed ID: 6219291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cryptococcal antigens on cell-mediated immunity.
    Murphy JW
    Rev Infect Dis; 1988; 10 Suppl 2():S432-5. PubMed ID: 2973118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.